pokerroom| Non-plague vaccines: There is a high possibility that non-plague vaccines will make significant progress in 2024, and clinical trial results may be available before the end of June

Source Gangtise Investment Research

Analysts said that since the outbreak of swine fever in Africa, non-plague vaccine research and development trials involving scientific research institutions such as the Chinese Academy of Sciences and Zhejiang Hailong have been carried outpokerroomIn 4 to 5 years, there is a high possibility that non-plague vaccines will make significant progress in 2024, and clinical trial results may be available before the end of June. If non-plague vaccines can be implemented in 2024, biological shares, Zhongmu shares and other targets are likely to benefit. The revenue increase of each company will reach 1 to 2 billion yuan, and the profit increase will be more than 500 million yuan.